EP1135476A4 - Compositions biologiques, leurs constituants et leurs applications - Google Patents

Compositions biologiques, leurs constituants et leurs applications

Info

Publication number
EP1135476A4
EP1135476A4 EP99957236A EP99957236A EP1135476A4 EP 1135476 A4 EP1135476 A4 EP 1135476A4 EP 99957236 A EP99957236 A EP 99957236A EP 99957236 A EP99957236 A EP 99957236A EP 1135476 A4 EP1135476 A4 EP 1135476A4
Authority
EP
European Patent Office
Prior art keywords
components
uses therefor
biological compositions
biological
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99957236A
Other languages
German (de)
English (en)
Other versions
EP1135476A1 (fr
Inventor
Stephen Alister Locarnini
Joseph Torresi
Linda Earnest-Silveira
Angeline Ingrid Bartholomeusz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Melbourne Health
Original Assignee
Melbourne Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Melbourne Health filed Critical Melbourne Health
Publication of EP1135476A1 publication Critical patent/EP1135476A1/fr
Publication of EP1135476A4 publication Critical patent/EP1135476A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10161—Methods of inactivation or attenuation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
EP99957236A 1998-11-11 1999-11-10 Compositions biologiques, leurs constituants et leurs applications Withdrawn EP1135476A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPP7060A AUPP706098A0 (en) 1998-11-11 1998-11-11 Biological compositions, components thereof and uses therefor
AUPP706098 1998-11-11
PCT/AU1999/000993 WO2000028009A1 (fr) 1998-11-11 1999-11-10 Compositions biologiques, leurs constituants et leurs applications

Publications (2)

Publication Number Publication Date
EP1135476A1 EP1135476A1 (fr) 2001-09-26
EP1135476A4 true EP1135476A4 (fr) 2006-01-25

Family

ID=3811273

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99957236A Withdrawn EP1135476A4 (fr) 1998-11-11 1999-11-10 Compositions biologiques, leurs constituants et leurs applications

Country Status (5)

Country Link
EP (1) EP1135476A4 (fr)
CN (1) CN1330712A (fr)
AU (1) AUPP706098A0 (fr)
HK (1) HK1043479A1 (fr)
WO (1) WO2000028009A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP967999A0 (en) * 1999-04-09 1999-05-06 North Western Health Care Network Viral variants
GB9908263D0 (en) * 1999-04-13 1999-06-02 Binding Site The Limited Eliciting improved immune responses
AUPQ810900A0 (en) * 2000-06-09 2000-07-06 Austin and Repatriation Medical Centre, The Viral variants and methods of using same
KR101281098B1 (ko) * 2011-06-30 2013-07-02 주식회사 녹십자 Ｂ형 간염 바이러스 표면 항원상의 에피토프 및 이의 용도

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998021317A1 (fr) * 1996-11-08 1998-05-22 Western Health Care Network Variantes virales et leurs procedes de detection

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994012617A1 (fr) * 1992-11-25 1994-06-09 International Biotechnology Laboratories, Inc. Vaccins contre le virus de l'hepatite b
US5595739A (en) * 1993-05-07 1997-01-21 Abbott Laboratories Hepatitis B virus mutants, reagents and methods for detection
CA2224477A1 (fr) * 1995-06-20 1997-01-09 Margherita Melegari Inhibition de la replication du virus de l'hepatite b
AUPO434196A0 (en) * 1996-12-24 1997-01-23 Crown In The Right Of The Queensland Department Of Health, The An improved therapeutic
JP2002507393A (ja) * 1998-02-11 2002-03-12 マキシジェン， インコーポレイテッド 抗原ライブラリー免疫

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998021317A1 (fr) * 1996-11-08 1998-05-22 Western Health Care Network Variantes virales et leurs procedes de detection

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
AYE THEIN THEIN ET AL: "Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation", JOURNAL OF HEPATOLOGY, MUNKSGAARD INTERNATIONAL PUBLISHERS, COPENHAGEN, DK, vol. 26, no. 5, 1997, pages 1148 - 1153, XP002303530, ISSN: 0168-8278 *
BARTHOLOMEUSZ A ET AL: "MUTATIONS IN THE HEPATITIS B VIRUS POLYMERASE GENE THAT ARE ASSOCIATED WITH RESISTANCE TO FAMCICLOVIR AND LAMIVUDINE", INTERNATIONAL ANTIVIRAL NEWS, CHURCHILL LIVINGSTONE, EDINBURGH, GB, vol. 5, no. 8, 1997, pages 123 - 124, XP002044248, ISSN: 0965-2310 *
BARTHOLOMEUSZ A ET AL: "SIGNIFICANCE OF MUTATIONS IN THE HEPATITIS B VIRUS POLYMERASE SELECTED BY NUCLEOSIDE ANALOGUES AND IMPLICATIONS FOR CONTROLLING CHRONIC DISEASE", VIRAL HEPATITIS REVIEWS, SAUNDERS, PHILADELPHIA, PA, US, vol. 4, no. 3, 1998, pages 167 - 187, XP000863517, ISSN: 1081-7050 *
GHANY M G ET AL: "HEPATITIS B VIRUS S MUTANTS IN LIVER TRANSPLANT RECIPIENTS WHO WERE REINFECTED DESPITE HEPATITIS B IMMUNE GLOBULIN PROPHYLAXIS", HEPATOLOGY, WILLIAMS AND WILKINS, BALTIMORE, MD, US, vol. 27, no. 1, January 1998 (1998-01-01), pages 213 - 222, XP009039932, ISSN: 0270-9139 *
See also references of WO0028009A1 *

Also Published As

Publication number Publication date
HK1043479A1 (zh) 2002-09-13
EP1135476A1 (fr) 2001-09-26
WO2000028009A1 (fr) 2000-05-18
AUPP706098A0 (en) 1998-12-03
CN1330712A (zh) 2002-01-09

Similar Documents

Publication Publication Date Title
ZA989560B (en) Compositions containing an Ó 1,2-fucose linkage and uses thereof.
BG105437A (en) REFLECTIVELY MODIFIED COMPOSITIONS AND METHODS FOR OBTAINING THEM
MXPA01002531A (es) Composicion cosmetica.
GB9809058D0 (en) Composition
GB9819530D0 (en) Novel compositions and use
GB9712317D0 (en) Composition, compound and use
GB9817235D0 (en) Compound,composition and use
GB9812119D0 (en) Composition
GB9817236D0 (en) Compound,composition and use
GB9806788D0 (en) Composition
GB9718876D0 (en) Compound,composition and use
GB9903447D0 (en) Compound, composition and use
GB9827894D0 (en) Composition
GB9806793D0 (en) Composition
GB9817238D0 (en) Compound,composition and use
ZA200006118B (en) Novel composition.
GB9914796D0 (en) Composition
HK1043479A1 (zh) 生物學組合物及其成分和用途
ZA200000192B (en) Novel composition.
GB9804041D0 (en) Composition
GB9723859D0 (en) Compound,composition and use
IL142278A0 (en) Imidazo-isoquinoline compounds, their compositions and uses
GB9723858D0 (en) Compound,composition and use
GB9723856D0 (en) Compound,composition and use
GB9723853D0 (en) Compound, composition and use

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010611

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL PAYMENT 20010608;LT PAYMENT 20010608;LV PAYMENT 20010608;MK PAYMENT 20010608;RO PAYMENT 20010608;SI PAYMENT 20010608

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 07K 14/02 B

Ipc: 7A 61K 39/29 B

Ipc: 7C 12N 15/00 A

A4 Supplementary search report drawn up and despatched

Effective date: 20051213

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20060322